SerpinA9 Antibodies

Santa Cruz Biotechnology offers a broad range of SerpinA9 monoclonal antibodies for advanced research in protein biology. SerpinA9 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SerpinA9, also known as Serpin B9, plays a critical role in regulating apoptosis and immune responses by inhibiting serine proteases. SerpinA9 expression significantly influences tumor progression and immune evasion mechanisms in cancer research. Understanding SerpinA9 activity and regulation is essential for elucidating its role in various pathological conditions. Researchers can investigate SerpinA9's molecular interactions and cellular distribution patterns through multiple experimental approaches. Current studies focus on how SerpinA9 influences cellular survival pathways and immune system modulation. Ongoing research continues to reveal new insights about SerpinA9's involvement in disease progression and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SerpinA9's role in human health and disease.